How Can We Help?
Skip to content
Wire frame hand with test tube


ADME & DDI Contract Research Organization Announces New Website Launch

  • September 18, 2020

KANSAS CITY, Kansas– SEKISUI XenoTech, a specialty contract research organization (CRO) providing superior nonclinical studies and assay products to pharmaceutical...

SEKISUI XenoTech Receives New US Patent for a Method to Evaluate Xenobiotics as Immune-Modulators of Drug Transport and Metabolism in Hepatocytes

  • May 12, 2020

Kansas City, KS– SEKISUI XenoTech has been awarded US patent # 10,648,968 “In vitro test system to evaluate xenobiotics as...

SEKISUI XenoTech Expands Access to Top-Tier DDI Expertise & Consultancy

  • May 4, 2020

Kansas City, KS – SEKISUI XenoTech is expanding opportunities for clients to work with top-tier consultants to evaluate drug-drug interaction...

New Head of KC-Based Drug Development CRO Poised for Further Growth and Expansion

  • January 28, 2020

SEKISUI XenoTech announces the promotion of Dr. Darren Warren to President and Chief Executive Officer...

SEKISUI XenoTech Announces Expanded Consulting Opportunities Available to Clients

  • September 5, 2019

Kansas City, KS- SEKISUI XenoTech now provides the opportunity for clients to work with top-tier consultants to analyze critical components...

SEKISUI XenoTech Announces Enhanced Synergy in ADME Testing Services

  • July 2, 2019

Kansas City, KS– SEKISUI XenoTech is collaborating with the Drug Development Solutions Center to offer a full suite of nonclinical testing services specializing in...

SEKISUI XenoTech Celebrates 25th Anniversary

  • July 1, 2019

In 2019, SEKISUI XenoTech celebrated its 25th birthday, and our Japan branch turned 64! Read about our journey from a...

SEKISUI XenoTech Achieves Record Revenue and Employment Numbers

  • May 21, 2019

Kansas City, KS – SEKISUI XenoTech will celebrate its 25th anniversary this November, coming into the year with record-breaking achievements. Expansions reflect growth...

SEKISUI XenoTech Expands Partnership for Japanese Collection of Research Bioresources Cell Bank (JCRB) Distribution

  • January 8, 2019

Exclusive Distributor for JCRB Cell Lines in North America and Europe Kansas City, KS (January 8, 2019) – After 3...

SEKISUI XenoTech Announces Creation of Scientific Advisory Board (SAB)

  • December 5, 2018

Kansas City, KS- SEKISUI XenoTech has created a Scientific Advisory Board (SAB) of renowned scientists and thought leaders in the pharmaceutical industry. Initially...